Sign In

Ron Miller

Director, Global Pricing & Market Access - Oncology at Daiichi Sankyo, Inc.

Professional Background

Ron Miller is a seasoned expert in U.S. and global strategic pricing, market access, contracting, and reimbursement within the pharmaceutical and biotechnology sectors. With a comprehensive understanding of the intricacies of both domestic and international pricing structures, Ron has honed his skills to drive strategic decision-making in organizations that seek to enhance their market presence while managing costs and ensuring patient access to vital therapies. Currently serving as the Director of Global Pricing & Market Access for Oncology at Daiichi Sankyo, Inc., Ron leads initiatives that maximize access to critical cancer treatments through effective pricing strategies and reimbursement methodologies.

Previously, Ron held pivotal roles in various prestigious companies. As the Director of U.S. Strategic Pricing & Contracting at Ipsen US, he played an instrumental role in navigating the complex landscape of U.S. market access, leveraging his insights into health economics and outcomes research (HEOR) to support pricing strategies that align with market expectations and regulatory requirements. His tenure at Eisai US as Associate Director of U.S. Strategic Pricing & Contracting further solidified his reputation as a key player in pricing and market strategy, focusing on lifecycle price management and competitive responses.

Ron’s career has also included significant positions at Warner Chilcott, Aptalis Pharmaceutical Technologies, and Johnson & Johnson, where he managed a variety of contracting roles, from institutional contracts to specialty markets. His multifaceted expertise encompasses a deep knowledge of pricing analysis, rebates, discounts, and government price impacts, making him an asset to any organization striving for excellence in market access and commercial effectiveness.

Education and Achievements

Ron Miller's academic foundation is as robust as his professional experience. He holds a Master of Business Administration (M.B.A.) in Management from Fairleigh Dickinson University, where he acquired the strategic thinking and leadership skills essential for navigating the complex world of pharmaceutical pricing and market access. Prior to his MBA, he earned a Bachelor of Arts (B.A.) in Political Economy from the University of Hartford. This unique combination of business and economic education equips Ron with a broader perspective on market dynamics and regulatory frameworks, enhancing his effectiveness in the industry.

Ron completed his secondary education at Watchung Hills Regional High School, engaging in a curriculum that fostered his analytical capabilities and set the stage for his future academic and professional pursuits.

Beyond his formal education, Ron is known for his commitment to continuous learning and professional development. He regularly engages in industry training and seminars to stay current with shifts in healthcare policy, market trends, and the evolving landscape of pricing and access in the pharmaceutical field. His passion for knowledge is evident in his ability to effectively communicate complex economic concepts to diverse stakeholders, including healthcare providers, payers, and internal teams.

Achievements

Throughout his distinguished career, Ron Miller has made several notable contributions to the fields of pharmaceutical pricing and market access. His work has resulted in improved access to medications for patients by ensuring that pricing aligns with perceived value and healthcare outcomes.

As Director of Global Pricing & Market Access at Daiichi Sankyo, Ron’s leadership has helped the organization navigate challenging reimbursement environments while successfully launching new oncology products. Ron's strategic initiatives have led to the implementation of innovative pricing models that respond to market demands while remaining compliant with stringent regulatory guidelines.

His previous roles have further equipped him with a diverse toolkit for addressing market-specific challenges. At Ipsen US, he demonstrated his adeptness in developing comprehensive access strategies that addressed both commercial and government payer landscapes. Understanding the delicate balance required in pricing, Ron has effectively utilized health economics to formulate evidence-based justifications for pricing structures, thereby aiding in negotiations with payers.

At Johnson & Johnson, Ron's experience as Contract Manager involved leveraging analytics to optimize contract performance and managing the complexities linked to government pricing impacts. This multifaceted exposure not only enriches his decision-making capabilities but also enhances team collaboration through his ability to foster cross-functional relationships.

Moreover, in his varied roles, Ron has been instrumental in educating and guiding teams on best practices in pricing and contracting strategies, contributing to a culture of excellence that prioritizes patient access and fair pricing. His collaborative approach and leadership acumen have made him a respected figure in his field, where he continually seeks to drive meaningful improvements that benefit both the industry and patients alike.

Related Questions

How has Ron Miller influenced strategic pricing in the pharmaceutical industry?
What innovative strategies has Ron Miller implemented in global market access for oncology products?
How does Ron Miller leverage his education in Political Economy to impact his decisions in healthcare pricing?
What are some of the key challenges Ron Miller has faced in his contracting roles at major pharmaceutical companies?
How does Ron Miller's experience at Johnson & Johnson shape his approach to today's market access challenges?
Ron Miller
Add to my network

Location

New York City Metropolitan Area